摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-phenyl-6-propyl-4(3H)-pyrimidinone | 14727-24-3

中文名称
——
中文别名
——
英文名称
2-phenyl-6-propyl-4(3H)-pyrimidinone
英文别名
2-phenyl-6-propylpyrimidin-4(3H)-one;4-Oxo-6-propyl-2-phenyl-3,4-dihydro-pyrimidin;2-phenyl-6-propyl-3H-pyrimidin-4-one;2-Phenyl-6-propyl-3,4-dihydropyrimidin-4-one;2-phenyl-4-propyl-1H-pyrimidin-6-one
2-phenyl-6-propyl-4(3H)-pyrimidinone化学式
CAS
14727-24-3
化学式
C13H14N2O
mdl
MFCD12137508
分子量
214.267
InChiKey
KRSOVLHLLUQZRA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    41.5
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:b2786fdb00179586c62e2c8fcea6b9dd
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Regiospecific Bromination of 2-Phenyl-3<i>H</i>-pyrimidin-4-ones
    作者:Nilo Zanatta、Leonardo Fantinel、Liana Fernandes、Ana Wouters、Helio Bonacorso、Marcos Martins
    DOI:10.1055/s-0028-1083178
    日期:——
    Three methods for the regiospecific bromination of 2-phenyl-3H-pyrimidin-4-ones are presented: bromination of the 5-position of the pyrimidine ring, bromination of the 6-benzylic position and simultaneous bromination of both the 5-position of the pyrimidine ring and 6-benzylic position. Reactions were carried out using simple protocols and the brominated pyrimidines were obtained in good yields.
    本文介绍了 3 种 2-苯基-3H-嘧啶-4-酮的特异性化方法:嘧啶环 5 位化、6-苄基位化以及嘧啶环 5 位和 6-苄基位同时化。反应采用简单的方案进行,嘧啶的收率很高。
  • Synthesis and Biological Evaluation of Novel Sigma-1 Receptor Antagonists Based on Pyrimidine Scaffold As Agents for Treating Neuropathic Pain
    作者:Yu Lan、Yin Chen、Xudong Cao、Juecheng Zhang、Jie Wang、Xiangqing Xu、Yinli Qiu、Tan Zhang、Xin Liu、Bi-Feng Liu、Guisen Zhang
    DOI:10.1021/jm501207r
    日期:2014.12.26
    The discovery and synthesis of a new series of pyrimidines as potent sigma-1 receptor (sigma R-1) antagonists, associated with pharmacological antineuropathic pain activity, are the focus of this article. The new compounds were evaluated in vitro in sigma-1 and sigma-2 receptor binding assays. The nature of the pyrimidine scaffold was crucial for activity, and a basic amine was shown to be necessary according to the known pharmacophoric model. The most promising derivative was 5-chloro-2-(4-chlorophenyl)-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (137), which exhibited a high binding affinity to sigma R-1 receptor (K-i sigma(1) = 1.06 nM) and good sigma-1/2 selectivity (1344-fold). In in vivo tests, compound 137 exerted dose-dependent antinociceptive effects in mice formalin model and rats CCI models of neuropathic pain. In addition, no motor impairments were found in rotarod tests; acceptable pharmacokinetic properties were also noted. These data suggest compound 137 may constitute a novel class of drugs for the treatment of neuropathic pain.
  • SAKAMOTO, TAKAO;SAKASAI, TAKEJI;YOSHIZAWA, HIROSHI;TANJI, KEN-ICHI;NISHIM+, CHEM. AND PHARM. BULL., 1983, 31, N 12, 4554-4560
    作者:SAKAMOTO, TAKAO、SAKASAI, TAKEJI、YOSHIZAWA, HIROSHI、TANJI, KEN-ICHI、NISHIM+
    DOI:——
    日期:——
查看更多